Funded Clinical Trial for Dogs with Malignant Tumors
Trial Summary
A clinical trial to evaluate a novel anti-cancer therapy is now available. The study is designed into two phases. The initial phase will evaluate the safety of this drug in dogs with any measurable cancer (excluding hemangiosarcoma). The 2nd phase will evaluate the safety of this drug in dogs with hemangiosarcoma exclusively. No placebo is used.
In both phases, dogs will receive the study drug as daily, oral treatment with evaluations performed once weekly for the first 28 days, then once monthly. Blood sample collection and tumor biopsies are collected throughout the study to assess the metabolism and biological activity of this drug. Dogs with hemangiosarcoma will not receive biopsies.
During the course of the study, dogs will not be allowed any holistic therapy, chemotherapy, or other investigational therapies unless approved by the investigator and the sponsor.
Trial Support and Funding
Study drug, diagnostic tests, and follow-up exams will be paid for by the study sponsor. In the event that side effects are attributed to the study drug, the study will pay for medical management of the side effects.
Client-owned pet dogs that meet the following criteria:
- Histological or cytological diagnosis of cancer - excluding hemangiosarcoma in the first phase of the study;
- Measurable cancer that is amenable to serial biopsy;
- Generally feeling well;
- Prior treatment with chemotherapy accepted but a washout of 21 days is required;
- Prior treatment with non-steroidal anti-inflammatory drugs (NSAID) and prednisone accepted but a 14-day washout is required;
- Prior treatment with radiation therapy is accepted but a 30-day washout is required;
- No prior small molecule inhibitors (i.e. Palladiaâ„¢);
- No prior immunotherapy (i.e. Melanoma Vaccine);
Trial Participation
The following sites are evaluating patients for participation in this clinical trial:
The Oncology Service
Friendship Hospital for Animals
4105 Brandywine St., NW
Washington, DC 20016
(202) 363-7300
The Oncology Service
The LifeCentre
165 Fort Evans Rd. NE
Leesburg, VA 20176
(571) 439-6655
Red Bank Veterinary Hospital
197 Hance Ave.
Tinton Falls, NJ 07724
(732) 747-3636
New England Veterinary Oncology Group
180 Bear Hill Rd., Suite C
Waltham, MA 02451
(781) 684-8688









Pet owners seeking novel treatment options for animals with serious health conditions find an Animal Clinical Investigation network veterinarian participating in a clinical trial.
Animal Clinical Investigation network veterinarian and pet owner work together to determine whether the pet is eligible for the trial. Eligible pets begin treatment at an ACI network hospital.
Information from the trial is used to help develop new drugs and treatments, providing a source of hope for people whose pets face serious illnesses.